Related references
Note: Only part of the references are listed.Potential Role for Plasma Placental Growth Factor in Predicting Coronary Heart Disease Risk in Women
Aedin Cassidy et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
The effect of marine n-3 fatty acids in different doses on plasma concentrations of Lp-PLA2 in healthy adults
Maria Weinkouff Pedersen et al.
EUROPEAN JOURNAL OF NUTRITION (2009)
25-hydroxyvitamin D and risk of myocardial infarction in men - A prospective study
Edward Giovannucci et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Cardiovascular events with increased lipoprotein-associated phospholipase A2 and low high-density lipoprotein-cholesterol -: The veterans affairs HDL intervention trial
Sander J. Robins et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Influence of race and sex on lipoprotein-associated phospholipase A2 levels: Observations from the Dallas Heart Study
Emmanouil S. Brilakis et al.
ATHEROSCLEROSIS (2008)
Effects of the direct lipoprotein-associated phospholipase A2 inhibitor darapladib on human coronary atherosclerotic plaque
Patrick W. Serruys et al.
CIRCULATION (2008)
Lipoprotein-associated phospholipase A(2), hormone use, and the risk of ischemic stroke in postmenopausal women
Sylvia Wassertheil-Smoller et al.
HYPERTENSION (2008)
Distribution and correlates of lipoprotein-associated phospholipase A2 in an elderly cohort:: The Cardiovascular Health Study
Curt D. Furberg et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2008)
Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development
Robert L. Wilensky et al.
NATURE MEDICINE (2008)
Effects of a low-calorie diet associated with weight loss on lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) activity in healthy obese women
T. Tzotzas et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2008)
Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease
Marc S. Sabatine et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Association of lipoprotein-associated phospholipase A2 with coronary calcification among American and Japanese men
Airnan El-Saed et al.
JOURNAL OF EPIDEMIOLOGY (2007)
The association between lipoprotein-associated phospholipase A2 and cardiovascular disease and total mortality in vascular medicine patients
Matthew A. Allison et al.
JOURNAL OF VASCULAR SURGERY (2007)
Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects
Margaretha Persson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Comprehensive evaluation of genetic and environmental factors influencing the plasma lipoprotein-associated phospholipase A2 activity in a Japanese population
Shao-Yan Zhang et al.
HYPERTENSION RESEARCH (2007)
Role of lipoprotein-associated phospholipase A2 in leukocyte activation and inflammatory responses
Yi Shi et al.
ATHEROSCLEROSIS (2007)
The epidemiology of Lp-PLA2:: Distribution and correlation with cardiovascular risk factors in a population-based cohort
Margaretha Persson et al.
ATHEROSCLEROSIS (2007)
The role of lipoprotein-associated phospholipase A2 in the metabolic syndrome and diabetes
Hiroshi Noto et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2006)
Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary death
Heidi T. May et al.
AMERICAN HEART JOURNAL (2006)
Lipoprotein-associated phospholipase A2 and prognosis after myocardial infarction in the community
Yariv Gerber et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke
Mitchell S. V. Elkind et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Meta-analysis of data from the six primary prevention trials of cardiovascular events using aspirin
Alfred A. Bartolucci et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress
Wolfgang Koenig et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin or atorVastatin evaluation and infection therapy-thrombolysis in myocardial infarction) trial
M O'Donoghue et al.
CIRCULATION (2006)
Lipoprotein-associated phospholipase A2 and measures of extracoronary atherosclerosis - The Rotterdam study
I Kardys et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Lipoprotein-associated phospholipase A(2) is an independent marker for coronary endothelial dysfunction in humans
EH Yang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study
CM Ballantyne et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Drinking frequency, mediating biomarkers, and risk of myocardial infarction in women and men
KJ Mukamal et al.
CIRCULATION (2005)
Association between Lp-PLA2 and coronary artery disease:: Focus on its relationship with lipoproteins and markers of inflammation and hemostasis
N Khuseyinova et al.
ATHEROSCLEROSIS (2005)
Role of lipoprotein-associated phospholipase A2 in atherosclerosis -: Biology, epidemiology, and possible therapeutic target
A Zalewski et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Clinical review:: Lipoprotein-associated phospholipase A2, a novel inflammatory biomarker and independent risk predictor for cardiovascular disease
K Sudhir
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke - The Rotterdam Study
HHS Oei et al.
CIRCULATION (2005)
Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up
ES Brilakis et al.
EUROPEAN HEART JOURNAL (2005)
Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study
CM Ballantyne et al.
CIRCULATION (2004)
Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population -: Results from the 14-year follow-up of a large cohort from southern Germany
W Koenig et al.
CIRCULATION (2004)
Lipoprotein-associated phospholipase A2 (platelet-activating factor acetylhydrolase) and cardiovascular disease
MJ Caslake et al.
CURRENT OPINION IN LIPIDOLOGY (2003)
Plasma PAF-acetylhydrolase in patients with coronary artery disease: results of a cross-sectional analysis
S Blankenberg et al.
JOURNAL OF LIPID RESEARCH (2003)
Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease.
CJ Packard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
